|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Johnson_&_Johnson
|
|
gptkbp:collaboratesWith
|
government agencies
academic institutions
biotechnology companies
|
|
gptkbp:focusesOn
|
biopharmaceuticals
|
|
gptkbp:foundedBy
|
gptkb:Janssen_Pharmaceutica
|
|
gptkbp:hasPart
|
gptkb:Janssen_Vaccines_&_Prevention
gptkb:Janssen_Pharmaceuticals
gptkb:Janssen_Research_&_Development
|
|
gptkbp:hasProductLine
|
gptkb:Xarelto
gptkb:Tremfya
gptkb:Janssen_COVID-19_Vaccine
gptkb:Aptivus
gptkb:Simponi
gptkb:Tysabri
gptkb:Nucala
gptkb:Invega
Erleada
Stelara
Darzalex
Sirturo
Spravato
Zytiga
Vraylar
Cablivi
Ninlaro
Apalutamide
Invokana
Sustol
Xofigo
|
|
gptkbp:hasResearchFocus
|
oncology
neuroscience
infectious diseases
immunology
|
|
gptkbp:headquarteredIn
|
gptkb:Leiden,_Netherlands
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Janssen Biologics
|
|
gptkbp:offers
|
therapeutics for autoimmune diseases
therapeutics for infectious diseases
therapeutics for cardiovascular diseases
therapeutics for oncology
|
|
gptkbp:operatesIn
|
global market
|
|
gptkbp:parentCompany
|
gptkb:Johnson_&_Johnson
|